Chris D’Agostino represents clients in the full spectrum of white collar criminal defense and internal corporate investigations.

Chris leverages extensive experience across a broad range of high-stakes and sensitive matters to guide companies in numerous industries through the full life cycle of investigative matters. He counsels technology companies, healthcare companies, multinational banks, energy companies, and large retail chains facing criminal and civil inquiries from regulatory authorities, including the:

  • US Department of Justice (DOJ)
  • Federal Trade Commission (FTC)
  • Securities and Exchange Commission (SEC)
  • Treasury Department’s Office of Foreign Assets Control (OFAC)
  • Drug Enforcement Administration (DEA)

In addition to his government-facing investigations practice, Chris regularly advises companies on designing and implementing anti-corruption and anti-money laundering compliance programs. He also conducts due diligence and advises clients on cross-border M&A and capital markets transactions from an anti-corruption and anti-money laundering compliance perspective.

A recognized leader at the firm, Chris serves on the Charitable Contribution and Community Service Committee and maintains a robust pro bono practice.

Chris’ white collar defense and investigations experience includes representing:

  • Global oilfield services companies in Foreign Corrupt Practices Act (FCPA) and sanctions-related investigations by the DOJ and OFAC
  • A large healthcare company in a DOJ False Claims Act (FCA) investigation and the successful dismissal of follow-on litigation brought by a relator
  • A large retail company in resolving Bank Secrecy Act and fraud allegations brought by the FTC and DOJ
  • An entertainment company in response to allegations of accounting fraud and corruption
  • A multinational bank in relation to an inquiry from DOJ regarding compliance with US sanctions, export controls, and anti-money laundering laws
  • A medical device company in the successful resolution of a False Claims Act investigation by DOJ
  • Healthcare companies in response to DEA inquiries related to the distribution of controlled substances
  • Several large technology companies in response to consumer inquiries from the FTC
  • Numerous organizations in the development of comprehensive anti-corruption and anti-money laundering compliance programs

Chris’ transactional experience includes advising:

  • Reddit on its US$748 million initial public offering (IPO)
  • e.l.f. Beauty on acquiring rhode
  • TPG on investing in K2 Medical Research
  • Ares Management Corporation on acquiring Crescent Point Capital
  • Oatly Group on its US$1.6 billion IPO
  • Platinum Equity on acquiring a controlling stake in SVP-Singer Holdings
  • Multi-Color Corporation on acquiring Hexagon
  • Amplitude on its direct listing

Bar Qualification

  • District of Columbia
  • New Jersey
  • New York

Education

  • JD, University of Virginia School of Law, 2015
  • BA, George Washington University, 2009
    summa cum laude